Fabrice Hurbin - Pharmacokinetics, Dynamics and Metabolism, Sanofi

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

523 - Efficacy and Safety of Amlitelimab (an Anti-Ox40 Ligand Antibody) in Patients with Moderate-to-severe Atopic Dermatitis: 24-Week Results from a Phase 2b Trial (STREAM-AD)

Stephan Weidinger,Andrew Blauvelt,Kim Papp, Adam Reich,Chih-Hung Lee,Margitta Worm,Charles Lynde, Yoko Kataoka, Peter Foley, Christine Weber, Wanling Wong,Fabrice Hurbin,Natalie Rynkiewicz,Karl Yen, Xiaodan Wei, John T O’Malley, Charlotte Bernigaud

British Journal of Dermatology（2024）

引用0浏览0引用

Pharmacokinetics of Alglucosidase Alfa Manufactured at the 4000‐L Scale in Participants with Pompe Disease: A Phase 3/4 Open‐Label Study

Xavier Nicolas,Fabrice Hurbin,Magali Periquet,Susan Richards,Charlotte Sensinger,Karen Welch,Kristina An Haack

Clinical pharmacology in drug developmentno. 12 (2023): 1185-1193

引用0浏览0WOS引用

Population Pharmacokinetic Modeling and Determination of Individual Exposure to Avalglucosidase Alfa in Adolescent and Adult Patients with Late-Onset Pompe Disease: Analysis of Pooled Data from Phase I to III Clinical Trials

Gilles Tuffal,Gilles Tiraboschi,Fabrice Hurbin, Pascale Boittet,Rachel Palmer,Jean-Marie Martinez,David Fabre

Therapeutic drug monitoringno. 5 (2023): 644-652

引用1浏览0WOS引用

Population Pharmacokinetic Modeling and Dosing Simulation of Avalglucosidase Alfa for Selecting Alternative Dosing Regimen in Pediatric Patients with Late-Onset Pompe Disease

Gilles Tiraboschi, David Marchionni,Gilles Tuffal,David Fabre,Jean-Marie Martinez,Kristina An Haack,Patrick Miossec,Barbara Kittner,Nadia Daba,Fabrice Hurbin

Journal of pharmacokinetics and pharmacodynamicsno. 6 (2023): 461-474

引用0浏览0WOS引用

First-in-human Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Doses of SAR247799, a Selective G-protein-biased Sphingosine-1 Phosphate Receptor-1 Agonist for Endothelial Protection

Luc Bergougnan,Sara Armani,Georg Golor,Agnes Tardat,Olivier Vitse,Fabrice Hurbin,Michel Scemama,Franck Poitiers,David Radzik,Christophe Gaudin,Lionel Hovsepian,Anthony J. Muslin,Stephane Kirkesseli,Paul Deutsch,Ashfaq A. Parkar

BJCP British journal of clinical pharmacology/British journal of clinical pharmacology（2020）

引用10浏览0WOS引用

Pharmacokinetics and Pharmacodynamics of Alirocumab, and Effects on PCSK9 and Low-Density Lipoprotein Cholesterol, in Japanese and Non-Japanese Patients

Fabrice HURBIN,Qiang LU,Marie T. BACCARA-DINET,Yoshiharu TAKAGI,Yoshihisa SHITARA, Seiko HORIUCHI,A. Thomas DiCIOCCIO,Masahiko KOBAYASHI,Aurélie BRUNET

Rinshou yakuri/Rinshō yakuri（2019）

引用1浏览0引用

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model-Support for a Biologics License Application Submission: Part I

Jean-Marie Martinez,Aurélie Brunet,Fabrice Hurbin,A Thomas DiCioccio,Clémence Rauch,David Fabre

Clinical pharmacokinetics（2019）

引用21浏览0WOS引用

Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part II

Xavier Nicolas,Nassim Djebli,Clémence Rauch,Aurélie Brunet,Fabrice Hurbin,Jean-Marie Martinez,David Fabre

Clinical pharmacokinetics（2018）

引用5浏览0WOS引用

Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies

Nassim Djebli,Jean-Marie Martinez,Laura Lohan,Sonia Khier,Aurélie Brunet,Fabrice Hurbin,David Fabre

Clinical pharmacokinetics（2017）

引用20浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn